Haematological and clinical features of β-thalassaemia associated with Hb Dhofar

Shahina Daar, David Gravell, Hussein M. Hussein, Anil V. Pathare, Yasser Wali, Rajagopal Krishnamoorthy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hb Dhofar is a variant haemoglobin (β29 (GGC-GGT) gly-gly, β58 (CCT-CGT) pro-arg) associated with a thalassaemic phenotype and unique to the Sultanate of Oman. We report clinical and haematological data on 54 subjects with Hb Dhofar (37 heterozygotes, 14 homozygotes and three compound heterozygotes with a different β-thalassaemia mutation). In heterozygotes, the level of Hb Dhofar ranged from 8.8% to 21.5%. All heterozygotes had Hb A2 > 3.5%, consistent with β-thalassaemia trait. Hb Dhofar in homozygotes and compound heterozygotes ranged from 26% to 59.7%, with a peripheral film consistent with homozygous β-thalassaemia. Age at presentation in homozygotes ranged between 6 months and 8 yr, with a majority presenting before 5 yr of age. All had splenomegaly and six (43%) had undergone splenectomy. All had some degree of frontal bossing and in particular, two patients with infrequent transfusions had marked thalassaemic facies and stunting of growth. Hb Dhofar can be mistaken for Hb D as the electrophoretic mobility is similar, but differs from it by a variable and reduced quantity of variant Hb in both heterozygotes and homozygotes. Clinical and haematological data suggest that this mutation behaves like a moderately severe β+ thalassaemia allele resulting in a thalassaemia intermedia phenotype.

Original languageEnglish
Pages (from-to)67-70
Number of pages4
JournalEuropean Journal of Haematology
Volume80
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Thalassemia
Heterozygote
Homozygote
prolylarginine
Growth Disorders
Oman
Phenotype
Mutation
beta-Thalassemia
Splenomegaly
Splenectomy
hemoglobin Dhofar
Hemoglobins
Alleles
Growth

Keywords

  • β-thalassaemia intermedia
  • Hb Dhofar
  • Oman

ASJC Scopus subject areas

  • Hematology

Cite this

Haematological and clinical features of β-thalassaemia associated with Hb Dhofar. / Daar, Shahina; Gravell, David; Hussein, Hussein M.; Pathare, Anil V.; Wali, Yasser; Krishnamoorthy, Rajagopal.

In: European Journal of Haematology, Vol. 80, No. 1, 01.2008, p. 67-70.

Research output: Contribution to journalArticle

Daar, Shahina ; Gravell, David ; Hussein, Hussein M. ; Pathare, Anil V. ; Wali, Yasser ; Krishnamoorthy, Rajagopal. / Haematological and clinical features of β-thalassaemia associated with Hb Dhofar. In: European Journal of Haematology. 2008 ; Vol. 80, No. 1. pp. 67-70.
@article{772ae2061fd8482bbf2d0519da60f451,
title = "Haematological and clinical features of β-thalassaemia associated with Hb Dhofar",
abstract = "Hb Dhofar is a variant haemoglobin (β29 (GGC-GGT) gly-gly, β58 (CCT-CGT) pro-arg) associated with a thalassaemic phenotype and unique to the Sultanate of Oman. We report clinical and haematological data on 54 subjects with Hb Dhofar (37 heterozygotes, 14 homozygotes and three compound heterozygotes with a different β-thalassaemia mutation). In heterozygotes, the level of Hb Dhofar ranged from 8.8{\%} to 21.5{\%}. All heterozygotes had Hb A2 > 3.5{\%}, consistent with β-thalassaemia trait. Hb Dhofar in homozygotes and compound heterozygotes ranged from 26{\%} to 59.7{\%}, with a peripheral film consistent with homozygous β-thalassaemia. Age at presentation in homozygotes ranged between 6 months and 8 yr, with a majority presenting before 5 yr of age. All had splenomegaly and six (43{\%}) had undergone splenectomy. All had some degree of frontal bossing and in particular, two patients with infrequent transfusions had marked thalassaemic facies and stunting of growth. Hb Dhofar can be mistaken for Hb D as the electrophoretic mobility is similar, but differs from it by a variable and reduced quantity of variant Hb in both heterozygotes and homozygotes. Clinical and haematological data suggest that this mutation behaves like a moderately severe β+ thalassaemia allele resulting in a thalassaemia intermedia phenotype.",
keywords = "β-thalassaemia intermedia, Hb Dhofar, Oman",
author = "Shahina Daar and David Gravell and Hussein, {Hussein M.} and Pathare, {Anil V.} and Yasser Wali and Rajagopal Krishnamoorthy",
year = "2008",
month = "1",
doi = "10.1111/j.1600-0609.2007.00989.x",
language = "English",
volume = "80",
pages = "67--70",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Haematological and clinical features of β-thalassaemia associated with Hb Dhofar

AU - Daar, Shahina

AU - Gravell, David

AU - Hussein, Hussein M.

AU - Pathare, Anil V.

AU - Wali, Yasser

AU - Krishnamoorthy, Rajagopal

PY - 2008/1

Y1 - 2008/1

N2 - Hb Dhofar is a variant haemoglobin (β29 (GGC-GGT) gly-gly, β58 (CCT-CGT) pro-arg) associated with a thalassaemic phenotype and unique to the Sultanate of Oman. We report clinical and haematological data on 54 subjects with Hb Dhofar (37 heterozygotes, 14 homozygotes and three compound heterozygotes with a different β-thalassaemia mutation). In heterozygotes, the level of Hb Dhofar ranged from 8.8% to 21.5%. All heterozygotes had Hb A2 > 3.5%, consistent with β-thalassaemia trait. Hb Dhofar in homozygotes and compound heterozygotes ranged from 26% to 59.7%, with a peripheral film consistent with homozygous β-thalassaemia. Age at presentation in homozygotes ranged between 6 months and 8 yr, with a majority presenting before 5 yr of age. All had splenomegaly and six (43%) had undergone splenectomy. All had some degree of frontal bossing and in particular, two patients with infrequent transfusions had marked thalassaemic facies and stunting of growth. Hb Dhofar can be mistaken for Hb D as the electrophoretic mobility is similar, but differs from it by a variable and reduced quantity of variant Hb in both heterozygotes and homozygotes. Clinical and haematological data suggest that this mutation behaves like a moderately severe β+ thalassaemia allele resulting in a thalassaemia intermedia phenotype.

AB - Hb Dhofar is a variant haemoglobin (β29 (GGC-GGT) gly-gly, β58 (CCT-CGT) pro-arg) associated with a thalassaemic phenotype and unique to the Sultanate of Oman. We report clinical and haematological data on 54 subjects with Hb Dhofar (37 heterozygotes, 14 homozygotes and three compound heterozygotes with a different β-thalassaemia mutation). In heterozygotes, the level of Hb Dhofar ranged from 8.8% to 21.5%. All heterozygotes had Hb A2 > 3.5%, consistent with β-thalassaemia trait. Hb Dhofar in homozygotes and compound heterozygotes ranged from 26% to 59.7%, with a peripheral film consistent with homozygous β-thalassaemia. Age at presentation in homozygotes ranged between 6 months and 8 yr, with a majority presenting before 5 yr of age. All had splenomegaly and six (43%) had undergone splenectomy. All had some degree of frontal bossing and in particular, two patients with infrequent transfusions had marked thalassaemic facies and stunting of growth. Hb Dhofar can be mistaken for Hb D as the electrophoretic mobility is similar, but differs from it by a variable and reduced quantity of variant Hb in both heterozygotes and homozygotes. Clinical and haematological data suggest that this mutation behaves like a moderately severe β+ thalassaemia allele resulting in a thalassaemia intermedia phenotype.

KW - β-thalassaemia intermedia

KW - Hb Dhofar

KW - Oman

UR - http://www.scopus.com/inward/record.url?scp=37249047466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249047466&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2007.00989.x

DO - 10.1111/j.1600-0609.2007.00989.x

M3 - Article

C2 - 18173741

AN - SCOPUS:37249047466

VL - 80

SP - 67

EP - 70

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 1

ER -